What is Tsumura & Co. (TSMRF)?

Tsumura & Co. (TSMRF) is a stock in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. View full analysis on Stocks360.

What is the current price of TSMRF?

The current price of TSMRF is $23.20. Prices are updated in real time on Stocks360.

What is TSMRF's price-to-earnings (PE) ratio?

TSMRF's trailing twelve-month PE ratio is 9.43, based on current price and earnings per share data available on Stocks360.

What is TSMRF's market capitalization?

TSMRF's market capitalization is $1,729,454,579.00, placing it in the small-cap tier.

Does TSMRF pay a dividend?

Yes. TSMRF has a trailing twelve-month dividend yield of 0.04%. Dividend data is sourced from financial market providers and displayed on Stocks360.

Tsumura & Co. (TSMRF)

Stock analysis · OTC · Healthcare · Drug Manufacturers - Specialty & Generic

$23.20

Market Cap

$1.73B

PE (TTM)

9.43

EPS (TTM)

N/A

Dividend Yield

4.14%

Beta

0.07

Day Range

$23.20 – $28.15

52-wk Range

$23.20 – $28.15

Avg Volume

N/A

Volume

100.00

Tsumura & Co. (TSMRF) is a publicly traded company in the Healthcare sector. Latest price: $23.20. Market cap $1.73B. Trailing PE 9.43. Dividend yield 4.14%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 7 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

1-Year Price

2025-10-31 · $23.20 2026-10-26 · $23.20 (+0.00%)

Earnings

Most Recent

May 12, 2026

EPS $0.42 vs est. $0.59

Missed by $0.17

Next Earnings

Nov 9, 2026

EPS estimate $0.69

Proprietary Signals

Signal snapshot temporarily unavailable.

About Tsumura & Co.

Tsumura & Co. is a global pharmaceutical company specializing in the production and distribution of various medicinal products. Their core offerings include Kampo extract intermediates and granular Kampo formulations. The company manages the comprehensive process of bringing these traditional remedies to market, from the sourcing, meticulous selection, and processing of raw herbal ingredients to their careful warehousing, including components prepared for traditional decoctions. Tsumura & Co. also manufactures powdered Kampo extracts and a range of traditional Chinese medical preparations. Beyond pharmaceuticals, the company additionally distributes food items. Established in 1893, Tsumura & Co. maintains its headquarters in Tokyo, Japan.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	9.43×
P/S (TTM)	1.43×
P/B	0.87×
PEG	0.48×
P/FCF (TTM)	-15.07×
EV / EBITDA	6.19×
EV / Sales	1.79×
Earnings Yield	10.61%
Free Cash Flow Yield	-6.63%
Dividend Yield	4.14%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$355.63B
Revenue (TTM)	$199.22B
Net Income (TTM)	$30.21B
Free Cash Flow (TTM)	-$19.48B
Net Debt	$70.79B
Working Capital	$254.88B
Gross Margin	46.98%
Operating Margin	17.76%
Net Margin	15.16%
Return on Equity	9.68%
Return on Invested Capital	4.75%